Last reviewed · How we verify
NCT03909386: BLITZ-AFCancer
Non-interventional Study on Patients With Atrial Fibrillation and Cancer
trial in Atrial Fibrillation in 1,514 participants. Completed in 30 September 2022.
30 September 2021
Quick facts
| Lead sponsor | Heart Care Foundation |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,514 |
| Start date | 26 June 2019 |
| Primary completion | 30 September 2021 |
| Estimated completion | 30 September 2022 |
| Sites | 147 locations across Italy, Netherlands, Belgium, Ireland, Portugal, Spain |
Conditions studied
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
- Cancer — all drugs for Cancer →
Sponsor
Heart Care Foundation
Who can join
18 and older, any sex, with Atrial Fibrillation or Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
AF and cancer frequently coexist. Since these patients are usually excluded from randomized trials, information on their management and outcome is scarce. Occurrence of relevant clinical events, such as ischemic and hemorrhagic and all-cause mortality and cardiovascular (CV) mortality occurring in patients treated or not with antithrombotic agents needs to be clarified. A prospective observational registry collecting information, in a real world setting, on the clinical profile of patients with these clinical conditions and on the use of antithrombotic drugs in patients with AF and cancer could improve our knowledge on the management of these high risk patients.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Risk of Atrial Fibrillation According to Cancer Type: A Nationwide Population-Based Study.
Yun JP, Choi EK, Han KD, Park SH, et al · · 2021 · cited 117× · PMID 34396327 · DOI 10.1016/j.jaccao.2021.03.006 -
Characteristics and Management of Patients With Cancer and Atrial Fibrillation: The BLITZ-AF Cancer Registry.
Gulizia MM, Turazza FM, Ameri P, Alings M, et al · · 2024 · cited 4× · PMID 39130025 · DOI 10.1016/j.jacadv.2024.100991
Verify or expand the search:
- PubMed search for NCT03909386
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Atrial Fibrillation
Currently open trials in the same condition.
- NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
- NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
- NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
- NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
- NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting
Other Heart Care Foundation trials
Trials by the same sponsor.
- NCT07252388 — EARLY: Educational Intervention to Improve Patient Awareness on Early LDL-C Lowering in Secondary Prevention · NA · not yet recruiting
- NCT07283809 — European Unified Registries for Heart Care Evaluation and Randomised Trials Italy · recruiting
- NCT06775028 — Integrated Approach in Frail Older People with Atrial Fibrillation · NA · recruiting
- NCT06316128 — EmploYEd Antithrombotic Therapies in Patients With Acute Coronary Syndromes HOspitalized in iTalian CCUs · completed
- NCT06279988 — BRING-UP 3 Heart Failure · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03909386 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Heart Care Foundation
- Last refreshed: 12 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03909386.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing